Key Points
-
Recent initiatives have outlined the strategies and goals of the mouse community to achieve complete functional annotation of the mouse genome.
-
Insertional mutagenesis strategies have proved invaluable for mouse genetics research, and new technologies aim to improve the usefulness of this approach.
-
The Velocigene system, developed by Regeneron Pharmaceuticals, uses a BAC recombination system to generate targeted knockouts faster and more efficiently than traditional gene targeting systems.
-
The mutagenic and chromosome engineering resource (MICER) is a resource of insertion vectors that can target specified genes for mutation with great efficiency and can allow the production of templates for chromosome engineering.
-
The progress of genome-wide gene-trap screens has been substantial, and the advent of expression screening allows for prescreening in culture for gene classes of interest.
-
Using the Cre/loxP system or exploiting the increased incidence of non-sister chromatid exchange in Bloom syndrome cells allows the induction of mitotic recombination in embryonic stem cells. These approaches can be used to generate biallelic homozygous mutations in culture for recessive genetic screens.
-
The optimization of several transposable elements has led to the development of efficient systems for in vivo transposon mutagenesis for forward genetic screens. These elements can also potentially be used for generating substrates for chromosome engineering, gain-of-function screens and somatic cell insertional mutagenesis in the mouse.
-
A synthesis of insertional mutagenesis technologies will be necessary to achieve complete genome coverage for functional annotation, and will compliment alternative approaches including chemical mutagenesis.
Abstract
Insertional mutagenesis has been at the core of functional genomics in many species. In the mouse, improved vectors and methodologies allow easier genome-wide and phenotype-driven insertional mutagenesis screens. The ability to generate homozygous diploid mutations in mouse embryonic stem cells allows prescreening for specific null phenotypes prior to in vivo analysis. In addition, the discovery of active transposable elements in vertebrates, and their development as genetic tools, has led to in vivo forward insertional mutagenesis screens in the mouse. These new technologies will greatly contribute to the speed and ease with which we achieve complete functional annotation of the mouse genome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Nadeau, J. H. et al. Sequence interpretation. Functional annotation of mouse genome sequences. Science 291, 1251–1255 (2001).
Austin, C. P. et al. The knockout mouse project. Nature Genet. 36, 921–924 (2004).
Auwerx, J. et al. The European dimension for the mouse genome mutagenesis program. Nature Genet. 36, 925–927 (2004). References 1–3 outline the goals and approaches to be used to achieve complete functional annotation of the mouse genome through mutagenesis and phenotype analysis. Reference 1 describes the establishment of the IMMC, and references 2 and 3 are a further refinement of approaches and goals that reflect the thoughts of the mouse community today.
Justice, M. J., Noveroske, J. K., Weber, J. S., Zheng, B. & Bradley, A. Mouse ENU mutagenesis. Hum. Mol. Genet. 8, 1955–1963 (1999).
Hrabe de Angelis, M. H. et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nature Genet. 25, 444–447 (2000).
Nolan, P. M. et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nature Genet. 25, 440–443 (2000).
Yang, X. W., Model, P. & Heintz, N. Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nature Biotechnol. 15, 859–865 (1997).
Yu, D. et al. An efficient recombination system for chromosome engineering in Escherichia coli. Proc. Natl Acad. Sci. USA 97, 5978–5983 (2000).
Testa, G. et al. Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles. Nature Biotechnol. 21, 443–447 (2003).
Yang, Y. & Seed, B. Site-specific gene targeting in mouse embryonic stem cells with intact bacterial artificial chromosomes. Nature Biotechnol. 21, 447–451 (2003).
Valenzuela, D. M. et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nature Biotechnol. 21, 652–659 (2003).
Adams, D. J. et al. Mutagenic insertion and chromosome engineering resource (MICER). Nature Genet. 36, 867–871 (2004). This paper describes the MICER system with regard to application, genome coverage and availability of insertion vectors for targeted mutagenesis in mouse ES cells.
Zheng, B., Mills, A. A. & Bradley, A. A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res. 27, 2354–2360 (1999).
Yu, Y. & Bradley, A. Engineering chromosomal rearrangements in mice. Nature Rev. Genet. 2, 780–790 (2001).
Durick, K., Mendlein, J. & Xanthopoulos, K. G. Hunting with traps: genome-wide strategies for gene discovery and functional analysis. Genome Res. 9, 1019–1025 (1999).
Stanford, W. L., Cohn, J. B. & Cordes, S. P. Gene-trap mutagenesis: past, present and beyond. Nature Rev. Genet. 2, 756–768 (2001).
Skarnes, W. C. et al. A public gene trap resource for mouse functional genomics. Nature Genet. 36, 543–544 (2004).
Zambrowicz, B. P. et al. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 392, 608–611 (1998). This paper describes the efforts of Lexicon Genetics to create an ES cell library that contains gene-trap insertions within every gene of the mouse. This work used a combined promoter-trap/poly(A)-trap vector to identify genes.
Stryke, D. et al. BayGenomics: a resource of insertional mutations in mouse embryonic stem cells. Nucleic Acids Res. 31, 278–281 (2003).
Zambrowicz, B. P. et al. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc. Natl Acad. Sci. USA 100, 14109–14114 (2003).
Shigeoka, T., Kawaichi, M. & Ishida, Y. Suppression of nonsense-mediated mRNA decay permits unbiased gene trapping in mouse embryonic stem cells. Nucleic Acids Res. 33, e20 (2005).
Hansen, J. et al. A large-scale, gene-driven mutagenesis approach for the functional analysis of the mouse genome. Proc. Natl Acad. Sci. USA 100, 9918–9922 (2003).
Bushman, F. D. Targeting survival: integration site selection by retroviruses and LTR-retrotransposons. Cell 115, 135–138 (2003).
Skarnes, W. C., Moss, J. E., Hurtley, S. M. & Beddington, R. S. Capturing genes encoding membrane and secreted proteins important for mouse development. Proc. Natl Acad. Sci. USA 92, 6592–6596 (1995).
Mitchell, K. J. et al. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nature Genet. 28, 241–249 (2001). This paper describes the use of a specialized gene-trap vector designed to trap exclusively genes that encode secreted and transmembrane proteins. It reports the characterization of one of the largest collections of mouse mutants elicited in ES cells using gene traps.
Leighton, P. A. et al. Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410, 174–179 (2001).
Zhang, W. et al. The functional landscape of mouse gene expression. J. Biol. 3, 21 (2004).
Hirashima, M., Bernstein, A., Stanford, W. L. & Rossant, J. Gene-trap expression screening to identify endothelial-specific genes. Blood 104, 711–718 (2004).
Medico, E., Gambarotta, G., Gentile, A., Comoglio, P. M. & Soriano, P. A gene trap vector system for identifying transcriptionally responsive genes. Nature Biotechnol. 19, 579–582 (2001).
Chen, Y. T., Liu, P. & Bradley, A. Inducible gene trapping with drug-selectable markers and Cre/loxP to identify developmentally regulated genes. Mol. Cell Biol. 24, 9930–9941 (2004).
Chen, W. V., Delrow, J., Corrin, P. D., Frazier, J. P. & Soriano, P. Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nature Genet 36, 304–312 (2004). This paper describes the coupling of gene-trap technology to microarray analysis. RACE products generated from gene-trap insertions of an ES cell library are spotted on a microarray to identify genes transcriptionally responsive to platelet-derived growth factor in wild-type or mutant cells. This allows identification of ES cell clones harbouring mutations in such genes.
Harrington, J. J. et al. Creation of genome-wide protein expression libraries using random activation of gene expression. Nature Biotechnol. 19, 440–445 (2001).
Pellegrini, S., John, J., Shearer, M., Kerr, I. M. & Stark, G. R. Use of a selectable marker regulated by αinterferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605–4612 (1989).
Zheng, B., Sage, M., Sheppeard, E. A., Jurecic, V. & Bradley, A. Engineering mouse chromosomes with Cre-loxP : range, efficiency, and somatic applications. Mol. Cell. Biol. 20, 648–655 (2000).
Koike, H. et al. Efficient biallelic mutagenesis with Cre/loxP-mediated inter-chromosomal recombination. EMBO Rep. 3, 433–437 (2002).
Liu, P., Jenkins, N. A. & Copeland, N. G. Efficient Cre-loxP-induced mitotic recombination in mouse embryonic stem cells. Nature Genet. 30, 66–72 (2002). References 35 and 36 are the first to report the induction of mitotic recombination in embryonic stem cells using the Cre/ loxP system to elicit homozygous mutations in culture.
Smith, A. J. et al. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nature Genet. 9, 376–385 (1995).
Ellis, N. A. et al. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83, 655–666 (1995).
German, J. Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine (Baltimore) 72, 393–406 (1993).
Groden, J., Nakamura, Y. & German, J. Molecular evidence that homologous recombination occurs in proliferating human somatic cells. Proc. Natl Acad. Sci. USA 87, 4315–4319 (1990).
Wu, L. & Hickson, I. D. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 426, 870–874 (2003).
Chester, N., Kuo, F., Kozak, C., O'Hara, C. D. & Leder, P. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Genes Dev. 12, 3382–33893 (1998).
Goss, K. H. et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297, 2051–2053 (2002).
Luo, G. et al. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nature Genet. 26, 424–429 (2000).
Guo, G., Wang, W. & Bradley, A. Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells. Nature 429, 891–895 (2004).
Yusa, K. et al. Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene. Nature 429, 896–899 (2004). References 45 and 46 were the first to exploit the increased incidence of somatic homologous recombination of cells deficient of the Bloom's RecQ helicase to produce biallelic mutations in diploid mouse ES cells.
Zwaal, R. R., Broeks, A., van Meurs, J., Groenen, J. T. & Plasterk, R. H. Target-selected gene inactivation in Caenorhabditis elegans by using a frozen transposon insertion mutant bank. Proc. Natl Acad. Sci. USA 90, 7431–7435 (1993).
Ross-Macdonald, P. et al. Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature 402, 413–418 (1999).
Schmidt, R. J., Burr, F. A. & Burr, B. Transposon tagging and molecular analysis of the maize regulatory locus opaque-2. Science 238, 960–963 (1987).
Spradling, A. C. et al. Gene disruptions using P transposable elements: an integral component of the Drosophila genome project. Proc. Natl Acad. Sci. USA 92, 10824–10830 (1995).
Bellen, H. J. et al. P-element-mediated enhancer detection: a versatile method to study development in Drosophila. Genes Dev. 3, 1288–1300 (1989).
Bier, E. et al. Searching for pattern and mutation in the Drosophila genome with a P-lacZ vector. Genes Dev. 3, 1273–1287 (1989).
Wilson, C. et al. P-element-mediated enhancer detection: an efficient method for isolating and characterizing developmentally regulated genes in Drosophila. Genes Dev. 3, 1301–1313 (1989).
Cooley, L., Kelley, R. & Spradling, A. Insertional mutagenesis of the Drosophila genome with single P elements. Science 239, 1121–1128 (1988).
Rorth, P. et al. Systematic gain-of-function genetics in Drosophila. Development 125, 1049–10457 (1998).
Duffy, J. B. GAL4 system in Drosophila: a fly geneticist's Swiss army knife. Genesis 34, 1–15 (2002).
Rorth, P. A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc. Natl Acad. Sci. USA 93, 12418–12422 (1996).
Kooistra, R., Pastink, A., Zonneveld, J. B., Lohman, P. H. & Eeken, J. C. The Drosophila melanogaster DmRAD54 gene plays a crucial role in double-strand break repair after P-element excision and acts synergistically with Ku70 in the repair of X-ray damage. Mol. Cell. Biol. 19, 6269–6275 (1999).
Moran, J. V. et al. High frequency retrotransposition in cultured mammalian cells. Cell 87, 917–927 (1996).
Ostertag, E. M. et al. A mouse model of human L1 retrotransposition. Nature Genet. 32, 655–660 (2002). This is the first described model of L1 transposition in the germline of mice.
Han, J. S. & Boeke, J. D. A highly active synthetic mammalian retrotransposon. Nature 429, 314–318 (2004).
Farley, A. H., Luning Prak, E. T. & Kazazian, H. H. Jr. More active human L1 retrotransposons produce longer insertions. Nucleic Acids Res. 32, 502–510 (2004).
Gilbert, N., Lutz-Prigge, S. & Moran, J. V. Genomic deletions created upon LINE-1 retrotransposition. Cell 110, 315–325 (2002).
Dewannieux, M., Dupressoir, A., Harper, F., Pierron, G. & Heidmann, T. Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells. Nature Genet. 36, 534–539 (2004).
Esnault, C. et al. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433, 430–433 (2005).
Koga, A., Suzuki, M., Inagaki, H., Bessho, Y. & Hori, H. Transposable element in fish. Nature 383, 30 (1996). This paper reports the identification of the first active endogenous DNA-based transposon in vertebrate species.
Koga, A. et al. The medaka fish Tol2 transposable element can undergo excision in human and mouse cells. J. Hum. Genet. 48, 231–235 (2003).
Kawakami, K. & Noda, T. Transposition of the Tol2 element, an Ac-like element from the Japanese medaka fish Oryzias latipes, in mouse embryonic stem cells. Genetics 166, 895–899 (2004).
Klinakis, A. G., Zagoraiou, L., Vassilatis, D. K. & Savakis, C. Genome-wide insertional mutagenesis in human cells by the Drosophila mobile element Minos. EMBO Rep. 1, 416–421 (2000).
Zagoraiou, L. et al. In vivo transposition of Minos, a Drosophila mobile element, in mammalian tissues. Proc. Natl Acad. Sci. USA 98, 11474–11478 (2001).
Drabek, D. et al. Transposition of the Drosophila hydei Minos transposon in the mouse germ line. Genomics 81, 108–111 (2003).
Schouten, G. J., van Luenen, H. G., Verra, N. C., Valerio, D. & Plasterk, R. H. Transposon Tc1 of the nematode Caenorhabditis elegans jumps in human cells. Nucleic Acids Res. 26, 3013–3017 (1998).
Zhang, L., Sankar, U., Lampe, D. J., Robertson, H. M. & Graham, F. L. The Himar1 mariner transposase cloned in a recombinant adenovirus vector is functional in mammalian cells. Nucleic Acids Res. 26, 3687–3693 (1998).
Ivics, Z., Hackett, P. B., Plasterk, R. H. & Izsvak, Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91, 501–510 (1997). This paper describes the resurrection of the Sleeping Beauty transposon system through site-directed mutagenesis to restore a consensus sequence based on several inactive salmon fish transposase genes.
Luo, G., Ivics, Z., Izsvak, Z. & Bradley, A. Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 95, 10769–10773 (1998).
Dupuy, A. J. et al. Mammalian germ-line transgenesis by transposition. Proc. Natl Acad. Sci. USA 99, 4495–4499 (2002).
Belur, L. R. et al. Gene insertion and long-term expression in lung mediated by the sleeping beauty transposon system. Mol. Ther. 8, 501–507 (2003).
Montini, E. et al. In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol. Ther. 6, 759–769 (2002).
Yant, S. R. et al. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nature Genet. 25, 35–41 (2000).
Ohlfest, J. R., Lobitz, P. D., Perkinson, S. G. & Largaespada, D. A. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system. Mol. Ther. 10, 260–268 (2004).
Dupuy, A. J., Fritz, S. & Largaespada, D. A. Transposition and gene disruption in the male germline of the mouse. Genesis 30, 82–88 (2001).
Fischer, S. E., Wienholds, E. & Plasterk, R. H. Regulated transposition of a fish transposon in the mouse germ line. Proc. Natl Acad. Sci. USA 98, 6759–6764 (2001).
Horie, K. et al. Efficient chromosomal transposition of a Tc1/mariner-like transposon Sleeping Beauty in mice. Proc. Natl Acad. Sci. USA 98, 9191–9196 (2001).
Carlson, C. M. et al. Transposon mutagenesis of the mouse germline. Genetics 165, 243–256 (2003).
Horie, K. et al. Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol. Cell. Biol. 23, 9189–9207 (2003). References 81–85 describe Sleeping Beauty -mediated transposition in the germline of mice doubly transgenic for transposon and transposase and its application to mouse genetics and in vivo gene-trapping.
Kile, B. T. et al. Functional genetic analysis of mouse chromosome 11. Nature 425, 81–86 (2003). This paper combined ENU mutagenesis with a balancer chromosome to facilitate a three-generation region-specific screen for mutant phenotypes.
Yant, S. R. et al. High-resolution genome-wide mapping of transposon integration in mammals. Mol. Cell. Biol. 25, 2085–2094 (2005).
Wu, X., Li, Y., Crise, B. & Burgess, S. M. Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749–1751 (2003).
Jonkers, J. & Berns, A. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta 1287, 29–57 (1996).
Carmell, M. A., Zhang, L., Conklin, D. S., Hannon, G. J. & Rosenquist, T. A. Germline transmission of RNAi in mice. Nature Struct Biol 10, 91–92 (2003).
Tiscornia, G., Singer, O., Ikawa, M. & Verma, I. M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl Acad. Sci. USA 100, 1844–1088 (2003).
Berns, K. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431–437 (2004).
Paddison, P. J. et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428, 427–431 (2004).
Beckers, J. & Hrabe de Angelis, M. Large-scale mutational analysis for the annotation of the mouse genome. Curr. Opin. Chem. Biol. 6, 17–23 (2002).
Lewandoski, M. Conditional control of gene expression in the mouse. Nature Rev. Genet. 2, 743–755 (2001).
Townley, D. J., Avery, B. J., Rosen, B. & Skarnes, W. C. Rapid sequence analysis of gene trap integrations to generate a resource of insertional mutations in mice. Genome Res. 7, 293–298 (1997).
Izsvak, Z., Ivics, Z. & Plasterk, R. H. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J. Mol. Biol. 302, 93–102 (2000).
Yusa, K., Takeda, J. & Horie, K. Enhancement of Sleeping Beauty transposition by CpG methylation: possible role of heterochromatin formation. Mol. Cell. Biol. 24, 4004–4018 (2004).
Zayed, H., Izsvak, Z., Khare, D., Heinemann, U. & Ivics, Z. The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acids Res. 31, 2313–2322 (2003).
Yant, S. R. & Kay, M. A. Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells. Mol. Cell. Biol. 23, 8505–8518 (2003).
Izsvak, Z. et al. Healing the wounds inflicted by sleeping beauty transposition by double-strand break repair in mammalian somatic cells. Mol. Cell 13, 279–290 (2004).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
David Largaespada is a co-founder and part owner of the biotechnology company Discovery Genetics Inc (DGI). DGI has licensed Sleeping Beauty technology from the University of Minnesota. DGI is pursuing the use of Sleeping Beauty for human gene therapy.
Related links
Glossary
- ES CELL LIBRARY
-
A collection of embryonic stem cell clones that contain a mutation at a distinct location of the genome.
- INSERTIONAL MUTAGENESIS
-
A mutation caused by the addition of DNA to effectively disrupt or alter the function of a given gene.
- ALLELIC SERIES
-
A panel of multiple mutations at distinct locations within the same gene, sometimes resulting in phenotypes that vary in severity or that are completely distinct.
- CHROMOSOME ENGINEERING
-
The controlled generation of chromosomal deletions, inversions or translocations with defined endpoints.
- NONSENSE-MEDIATED mRNA DECAY
-
The process by which the cell destroys mRNAs that are untranslatable owing to the presence of a nonsense codon within the coding region.
- EXPRESSION TRAPPING
-
The identification of ES cell clones from a library that contains gene-trap integrations within genes that are transcriptionally responsive to specific exogenous stimuli.
- HAPLOINSUFFICIENCY
-
The inability for the remaining wild-type allele to compensate for a heterozygous loss-of-function mutation.
- PRODRUG METRONIDAZOLE
-
A compound that when activated by nitrosoreductase is converted into a toxic alkylating agent.
- BLOOM SYNDROME
-
Human autosomal recessive disorder caused by a loss-of-function mutation in a RecQ helicase. It is characterized by genomic instability, increased incidence of sister chromatid exchange, and predisposition to an array of tumour types.
- RETROTRANSPOSONS
-
Transposable elements that mobilize by a 'copy and paste' mechanism. Retrotransposons are transcribed and then reverse transcribed by element-encoded enzymes. The resulting elements are subsequently integrated in the genomes, at a new location (for example, LINE-1 and intracisternal A particle).
- DNA TRANSPOSONS
-
Elements that mobilize by a 'cut and paste' mechanism with the transposon DNA being excised from its original location and inserted elsewhere by the transposase enzyme.
- TC1/MARINER TRANSPOSONS
-
DNA-based 'cut and paste' transposable elements found in numerous host organisms and having a small target sequence for integration (for example, Sleeping Beauty, Himar, Minos).
- CONTIGUOUS GENE SYNDROME
-
A multi-symptom disorder that is caused by a deletion of a large sequence of DNA that encodes several genes.
- BALANCER CHROMOSOME
-
A chromosome with an inversion (or multiple inversions) of an interval of DNA that represses meiotic recombination.
- HYPOMORPHIC ALLELE
-
A mutation in a gene that results in reduced expression or activity of the gene without complete loss of function.
Rights and permissions
About this article
Cite this article
Carlson, C., Largaespada, D. Insertional mutagenesis in mice: new perspectives and tools. Nat Rev Genet 6, 568–580 (2005). https://doi.org/10.1038/nrg1638
Issue Date:
DOI: https://doi.org/10.1038/nrg1638